INS and Hypokalemia: The fact that we have identified PI3Kα to mediate the insulin-induced protective effect can move the focus from the use of insulin (a “dirty” drug with many side effects, such as hypoglycemia, hypokalemia, and catecholamine elevation) to the development of pharmacological agents specifically targeting PI3Kα.